Articles with public access mandates - Vincenzo BronteLearn more
OverallGovernment of ItalyNIHAIRC Foundation for Cancer Research in ItalyEuropean CommissionDFGGovernment of SpainINSERMFondazione CariploSCLDoDNHMRCHelmholtzCancer Research UKSusan G. KomenHHMIFWFCIHRNSFCDFFOTKATelethonSwedish Research CouncilBlood Cancer UKNIHRANRBMBFKWFLeducq Foundation, USACanada First Research Excellence FundCZI
Not available anywhere: 7
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
S Walter, T Weinschenk, A Stenzl, R Zdrojowy, A Pluzanska, C Szczylik, ...
Nature medicine 18 (8), 1254-1261, 2012
Mandates: German Research Foundation
The pros and cons of chemokines in tumor immunology
A Viola, A Sarukhan, V Bronte, B Molon
Trends in immunology 33 (10), 496-504, 2012
Mandates: National Institute of Health and Medical Research, France
Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy
MS Sasso, G Lollo, M Pitorre, S Solito, L Pinton, S Valpione, G Bastiat, ...
Biomaterials 96, 47-62, 2016
Mandates: Government of Italy
Melanoma extracellular vesicles generate immunosuppressive myeloid cells by upregulating PD-L1 via TLR4 signaling
V Fleming, X Hu, C Weller, R Weber, C Groth, Z Riester, L Hüser, Q Sun, ...
Cancer Research 79 (18), 4715-4728, 2019
Mandates: German Research Foundation, Helmholtz Association
Myeloid-derived suppressor cell impact on endogenous and adoptively transferred T cells
A Arina, V Bronte
Current opinion in immunology 33, 120-125, 2015
Mandates: Government of Italy
Enhancing T cell therapy by overcoming the immunosuppressive tumor microenvironment
A Arina, L Corrales, V Bronte
Seminars in immunology 28 (1), 54-63, 2016
Mandates: Government of Italy
Adipocytes and neutrophils give a helping hand to pancreatic cancers
V Bronte, G Tortora
Cancer Discovery 6 (8), 821-823, 2016
Mandates: Government of Italy
Available somewhere: 95
Coordinated regulation of myeloid cells by tumours
DI Gabrilovich, S Ostrand-Rosenberg, V Bronte
Nature Reviews Immunology 12 (4), 253-268, 2012
Mandates: US National Institutes of Health
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
V Bronte, S Brandau, SH Chen, MP Colombo, AB Frey, TF Greten, ...
Nature communications 7 (1), 12150, 2016
Mandates: US National Institutes of Health, German Research Foundation, Helmholtz …
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
MZ Noman, G Desantis, B Janji, M Hasmim, S Karray, P Dessen, V Bronte, ...
Journal of Experimental Medicine 211 (5), 781-790, 2014
Mandates: Swiss Cancer League
The spleen in local and systemic regulation of immunity
V Bronte, MJ Pittet
Immunity 39 (5), 806-818, 2013
Mandates: US National Institutes of Health, Government of Italy
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
S Ugel, F De Sanctis, S Mandruzzato, V Bronte
The Journal of clinical investigation 125 (9), 3365-3376, 2015
Mandates: Government of Italy
Immune suppressive mechanisms in the tumor microenvironment
DH Munn, V Bronte
Current opinion in immunology 39, 1-6, 2016
Mandates: US National Institutes of Health, Government of Italy
Myeloid‐derived suppressor cell heterogeneity in human cancers
S Solito, I Marigo, L Pinton, V Damuzzo, S Mandruzzato, V Bronte
Annals of the New York Academy of Sciences 1319 (1), 47-65, 2014
Mandates: Government of Italy
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells
S Solito, E Falisi, CM Diaz-Montero, A Doni, L Pinton, A Rosato, ...
Blood, The Journal of the American Society of Hematology 118 (8), 2254-2265, 2011
Mandates: US National Institutes of Health
A relay pathway between arginine and tryptophan metabolism confers immunosuppressive properties on dendritic cells
G Mondanelli, R Bianchi, MT Pallotta, C Orabona, E Albini, A Iacono, ...
Immunity 46 (2), 233-244, 2017
Mandates: US National Institutes of Health, European Commission, Government of Italy
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
S Mandruzzato, S Brandau, CM Britten, V Bronte, V Damuzzo, ...
Cancer Immunology, Immunotherapy 65, 161-169, 2016
Mandates: German Research Foundation, Cancer Research UK, Government of Italy
Complexity and challenges in defining myeloid‐derived suppressor cells
V Damuzzo, L Pinton, G Desantis, S Solito, I Marigo, V Bronte, ...
Cytometry Part B: Clinical Cytometry 88 (2), 77-91, 2015
Mandates: Government of Italy
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
N Jacquelot, T Yamazaki, MP Roberti, CPM Duong, MC Andrews, ...
Cell research 29 (10), 846-861, 2019
Mandates: National Health and Medical Research Council, Australia, National Institute …
T cell cancer therapy requires CD40-CD40L activation of tumor necrosis factor and inducible nitric-oxide-synthase-producing dendritic cells
I Marigo, S Zilio, G Desantis, B Mlecnik, AHR Agnellini, S Ugel, MS Sasso, ...
Cancer cell 30 (3), 377-390, 2016
Mandates: US National Institutes of Health, Austrian Science Fund, National Institute …
Publication and funding information is determined automatically by a computer program